or Try an Advanced Search...

    Receptor Positive Stocks List

    Symbol Grade Name % Change
    GTHX A G1 Therapeutics, Inc. 0.00
    PRAX B Praxis Precision Medicines, Inc. -2.37
    ZNTL D Zentalis Pharmaceuticals, Inc. 21.61
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Antiestrogens Breast Cancer Cancer Drugs Estrogen Estrogen Receptor Her2 Her2/Neu Hormones Selective Estrogen Receptor Degraders Treatment Of Breast Cancer Antisense RNA Central Nervous System Disorders Depression Depressive Disorder Epidermal Growth Factor Receptor Epilepsy Essential Tremor Fulvestrant

    Related ETFs - A few ETFs which own one or more of the above listed Receptor Positive stocks.

    Symbol Grade Name Weight
    IBRN B iShares Neuroscience and Healthcare ETF 2.05
    ARB A AltShares Merger Arbitrage ETF 1.72
    CNCR F Loncar Cancer Immunotherapy ETF 1.22
    EVNT B AltShares Event-Driven ETF 0.77
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.42
    View all Receptor Positive ETFs...
    Compare ETFs
    Compare ARB to CNCR Compare ARB to LABD Compare CNCR to EVNT

        Receptor Positive Stocks Recent News

        Date Stock Title
        Nov 1 PRAX Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Antiestrogens Breast Cancer Cancer Drugs Estrogen Estrogen Receptor Her2 Her2/Neu Hormones Selective Estrogen Receptor Degraders Treatment Of Breast Cancer Antisense RNA Central Nervous System Disorders Depression Depressive Disorder Epidermal Growth Factor Receptor Epilepsy Essential Tremor Fulvestrant
        Receptor Positive

        Receptor positive refers to a type of cancer that has receptors on the surface of the cancer cells that can bind to certain hormones or other molecules. This can affect how the cancer cells grow and respond to treatments.

        Browse All Tags